| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Intellia Therapeutics, Inc.'s insiders have reduced their positions by a net 8,111 shares worth roughly $91K. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), NTLA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $12.18M | - | |
| Dir | 207.5K | $2.49M | - | |
| CFO | 148.2K | $1.78M | -8,111 | |
| Dir | 134.7K | $1.62M | - | |
| VP | 121.2K | $1.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | Bhanji Muna57 | Director | Sell | 265 | $9.97 | $2,642.05 | -1.3% | -19.0% | +37.4% | |
| Jan 3, 2025 | Leonard John M83 | President And CEO | Sell | 26,807 | $12.18 | $326,509.26 | -2.8% | -43.2% | -24.1% | |
| Jan 3, 2025 | Dube Michael P45 | VP, Chief Accounting Officer | Sell | 1,372 | $12.18 | $16,710.96 | -2.9% | -43.2% | -24.1% | |
| Jan 3, 2025 | Basta James72 | EVP, General Counsel | Sell | 7,074 | $12.18 | $86,161.32 | -8.7% | -43.2% | -24.1% | |
| Jan 3, 2025 | Lebwohl David87 | EVP, Chief Medical Officer | Sell | 9,557 | $12.18 | $116,404.26 | -9.8% | -43.2% | -24.1% | |
| Jan 3, 2025 | Hicks Derek71 | EVP, Chief Business Officer | Sell | 6,502 | $12.18 | $79,194.36 | -9.8% | -43.2% | -24.1% | |
| Jan 3, 2025 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sell | 8,966 | $12.18 | $109,205.88 | -10.4% | -43.2% | -24.1% | |
| Jan 3, 2025 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 7,978 | $12.17 | $97,088.64 | -5.6% | -43.2% | -24.1% | |
| Oct 2, 2024 | Dube Michael P45 | VP, Chief Accounting Officer | Sell | 2,012 | $19.01 | $38,248.12 | -4.1% | -37.1% | +10.2% | |
| Jul 1, 2024 | Clark Eliana75 | EVP, Chief Technical Officer | Sell | 405 | $22.93 | $9,286.65 | -0.6% | -8.5% | -56.0% |